The Clinical Implications of KRAS Mutations and Variant Allele Frequencies in Pancreatic Ductal Adenocarcinoma

F Nusrat, A Khanna, A Jain, W Jiang, H Lavu… - Journal of Clinical …, 2024 - mdpi.com
The KRAS proto-oncogene is a major driver of pancreatic tumorigenesis and is nearly
ubiquitously mutated in pancreatic ductal adenocarcinoma (PDAC). KRAS point mutations …